Annals of the Rheumatic Diseases: 82 (3)

Editorial

Occupational inhalants, genetics and the respiratory mucosal paradigm for ACPA-positive rheumatoid arthritis (6 December, 2022) Free
Vanessa L Kronzer, Jeffrey A Sparks

Review

From real-world electronic health record data to real-world results using artificial intelligence (23 September, 2022)
Rachel Knevel, Katherine P Liao

Viewpoint

Matching researchers’ needs and patients’ contributions: practical tips for meaningful patient engagement from the field of rheumatology (5 January, 2023)
Casper G Schoemaker, Dawn P Richards, Maarten de Wit

Rheumatoid arthritis

Occupational inhalable agents constitute major risk factors for rheumatoid arthritis, particularly in the context of genetic predisposition and smoking (6 December, 2022)
Bowen Tang, Qianwen Liu, Anna Ilar, Pernilla Wiebert, Sara Hägg, Leonid Padyukov, Lars Klareskog, Lars Alfredsson, Xia Jiang
Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis (30 November, 2022)
Daniel H Solomon, Jon T Giles, Katherine P Liao, Paul M Ridker, Pamela M Rist, Robert J Glynn, Rachel Broderick, Fengxin Lu, Meredith T Murray, Kathleen Vanni, Leah M Santacroce, Shady Abohashem, Philip M Robson, Zahi Fayad, Venkatesh Mani, Ahmed Tawakol, Joan Bathon
Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial (5 December, 2022)
Jeffrey R Curtis, Kunihiro Yamaoka, Yi-Hsing Chen, Deepak L Bhatt, Levent M Gunay, Naonobu Sugiyama, Carol A Connell, Cunshan Wang, Joseph Wu, Sujatha Menon, Ivana Vranic, Juan J Gómez-Reino
Tenderness and radiographic progression in rheumatoid arthritis and psoriatic arthritis (19 October, 2022)
Irina Gessl, Claudia A Hana, Thomas Deimel, Martina Durechova, Miriam Hucke, Victoria Konzett, Mihaela Popescu, Paul Studenic, Gabriela Supp, Michael Zauner, Josef S Smolen, Daniel Aletaha, Peter Mandl

Systemic lupus erythematosus

Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study (14 October, 2022)
Jingru Tian, Dingyao Zhang, Xu Yao, Yaqing Huang, Qianjin Lu

Systemic sclerosis

Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis (14 October, 2022)
Julia Z Adamska, Amin Zia, Michelle S Bloom, Leslie J Crofford, Daniel E Furst, Ellen Goldmuntz, Lynette Keyes-Elstein, Maureen D Mayes, Peter McSweeney, Richard A Nash, Ashley Pinckney, Beverly Welch, Zelda Z Love, Keith M Sullivan, William Robinson
Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis (5 December, 2022) Free
Sébastien Sanges, Lisa Rice, Ly Tu, Eleanor Valenzi, Jean-Luc Cracowski, David Montani, Julio C Mantero, Camille Ternynck, Guillemette Marot, Andreea M Bujor, Eric Hachulla, David Launay, Marc Humbert, Christophe Guignabert, Robert Lafyatis

Sjögren’s syndrome

Deciphering the role of cDC2s in Sjögren’s syndrome: transcriptomic profile links altered antigen processes with IFN signature and autoimmunity (28 September, 2022)
Ana P Lopes, Maarten R Hillen, Anneline C Hinrichs, Sofie LM Blokland, Cornelis PJ Bekker, Aridaman Pandit, Aike A Kruize, Timothy RDJ Radstake, Joel A van Roon

Osteoarthritis

Genome-wide association meta-analysis of knee and hip osteoarthritis uncovers genetic differences between patients treated with joint replacement and patients without joint replacement (14 November, 2022)
Cecilie Henkel, Unnur Styrkársdóttir, Gudmar Thorleifsson, Lilja Stefánsdóttir, Gyda Björnsdóttir, Karina Banasik, Søren Brunak, Christian Erikstrup, Khoa Manh Dinh, Thomas Folkmann Hansen, Kaspar René Nielsen, Mie Topholm Bruun, Joseph Dowsett, Thorsten Brodersen, DBDS Genomic Consortium, Thorgeir E Thorgeirsson, Kirill Gromov, Mikael Ploug Boesen, Henrik Ullum, Sisse Rye Ostrowski, Ole Birger Pedersen, Kári Stefánsson, Anders Troelsen
Stage-specific and location-specific cartilage calcification in osteoarthritis development (19 October, 2022)
Xiaozhao Wang, Qin Wu, Ru Zhang, Zhang Fan, Wenyue Li, Renwei Mao, Zihao Du, Xudong Yao, Yuanzhu Ma, Yiyang Yan, Wei Sun, Hongwei Wu, Wei Wei, Yejun Hu, Yi Hong, Huan Hu, Yi Wen Koh, Wangping Duan, Xiao Chen, Hongwei Ouyang
Senescent cell population with ZEB1 transcription factor as its main regulator promotes osteoarthritis in cartilage and meniscus (23 December, 2022)
Hannah Swahn, Kun Li, Tomas Duffy, Merissa Olmer, Darryl D D'Lima, Tony S Mondala, Padmaja Natarajan, Steven R Head, Martin K Lotz

Crystal arthropathies

Type II collagen facilitates gouty arthritis by regulating MSU crystallisation and inflammatory cell recruitment (15 September, 2022)
HanLin Xu, Bohan Zhang, Yaxin Chen, Fengzhen Zeng, Wenjuan Wang, Ziyi Chen, Ling Cao, Jun Shi, Jun Chen, Xiaoxia Zhu, Yu Xue, Rui He, MinBiao Ji, YingHui Hua

Animal models

Taxonomy of fibroblasts and progenitors in the synovial joint at single-cell resolution (22 November, 2022)
Fraser L Collins, Anke J Roelofs, Rebecca A Symons, Karolina Kania, Ewan Campbell, Elaina S R Collie-duguid, Anna H K Riemen, Susan M Clark, Cosimo De Bari

Letters

Database of synovial T cell repertoire of rheumatoid arthritis patients identifies cross-reactive potential against pathogens including unencountered SARS-CoV-2 (19 October, 2022)
Zihan Zheng, Ling Chang, Jie Mu, Qingshan Ni, Zhong Bing, Qing-Hua Zou, Ying Wan, Yuzhang Wu, Jingyi Li, Liyun Zou
Expression of interleukin-6 in synovial tissue of patients with polymyalgia rheumatica (12 August, 2022)
William F Jiemy, Anqi Zhang, Annemieke M H Boots, Peter Heeringa, Maria Sandovici, Arjan Diepstra, Sandra Hein, Bhaskar Dasgupta, Elisabeth Brouwer, Kornelis SM van der Geest
Deep immune profiling uncovers novel associations with clinical phenotypes of multisystem inflammatory syndrome in children (MIS-C) (24 November, 2022)
Christopher John Redmond, Moses M Kitakule, Aran Son, McKella Sylvester, Keith Sacco, Ottavia Delmonte, Francesco Licciardi, Riccardo Castagnoli, M Cecilia Poli, Yasmin Espinoza, Camila Astudillo, Sarah E Weber, Gina A Montealegre Sanchez, Karyl S Barron, Mary Magliocco, Kerry Dobbs, Yu Zhang, Helen Matthews, Cihan Oguz, Helen C Su, Luigi D Notarangelo, Pamela Frischmeyer-Guerrerio, Daniella M Schwartz
Genetically proxied TYK2 inhibition is associated with reduced sarcoidosis susceptibility (9 December, 2022)
Sizheng Steven Zhao, Anne Barton, John Bowes

EULAR news

News from EULAR (10 February, 2023) Free
EULAR Communications

Electronic pages

Correspondence on: ‘EULAR definition of difficult-to-treat rheumatoid arthritis’ (4 December, 2020) Free
Marta Novella-Navarro, Chamaida Plasencia-Rodríguez, Carolina Tornero, Victoria Navarro-Compán, José Luis Cabrera-Alarcón, Diana Peiteado, Laura Nuño, Irene Monjo, Karen Franco-Gómez, Alejandro Villalba, Alejandro Balsa
Response to: ‘Correspondence on ‘EULAR definition of difficult-to-treat rheumatoid arthritis’’ by Novella-Navarro et al
(4 December, 2020) Free
Nadia M T Roodenrijs, Paco M J Welsing, Marlies C van der Goes, Johannes WG Jacobs, Désirée van der Heijde, Jacob M van Laar, György Nagy
Correspondence on ‘Glucosamine and O-GlcNAcylation: a novel immunometabolic therapeutic target for OA and chronic, low-grade systemic inflammation?’ (27 January, 2021) Free
Socrates Angelides, Nicholas Manolios
Response to: ‘Correspondence on “Glucosamine and O-GlcNAcylation: a novel immunometabolic therapeutic target for OA and chronic, low-grade systemic inflammation?’ by Angelides and Manolios (27 January, 2021) Free
Gabriel Herrero-Beaumont, Raquel Largo
Correspondence on ‘Jan Gösta Waldenström and rheumatology’ (16 December, 2020) Free
Haralampos M Moutsopoulos
Response to: ‘Correspondence on ‘Jan Gösta Waldenströmand rheumatology’’ by Moutsopoulos (16 December, 2020) Free
Frank A Wollheim
Correspondence on ‘Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis’ (18 December, 2020) Free
Satoshi Takanashi
Response to: ‘Correspondence on ‘Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis’’ by Takanashi et al
(13 January, 2021) Free
Iago Pinal-Fernandez, Maria Casal-Dominguez, Jose Cesar Milisenda, Andrew Lee Mammen
Correspondence on ‘What comes after the lockdown? Clustering of ANCA-associated vasculitis: single-centre observation of a spatiotemporal pattern’ (6 January, 2021) Free
Samy Hakroush, Björn Tampe
Response to: ‘Correspondence on ‘What comes after the lockdown? Clustering of ANCA-associated vasculitis: single-centre observation of a spatiotemporal pattern’’ by Hakroush and Tampe (6 January, 2021) Free
Philipp Gauckler, Andreas Kronbichler
Correspondence on ‘Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension’
(16 December, 2020) Free
Michele Iudici, Danièle Allali, Raphaël Porcher
Response to: ‘ Correspondence on ‘Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension’’ by Iudici et al
(16 December, 2020) Free
Ekkehard Grünig, Nicola Benjamin, Panagiota Xanthouli, Suzana Jordan, Nicklas Milde, Alberto Marra, Norbert Blank, Benjamin Egenlauf, Matthias Gorenflo, Satenik Harutyunova, Hanns-Martin Lorenz, Christian Nagel, Vivienne Theobald, Mona Lichtblau, Charlotte Berlier, Silvia Ulrich, Oliver Distler
Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial’ (27 January, 2021) Free
Bin Wang, Shiju Chen, Jingxiu Xuan, Yan Li, Qing Zheng, Xinwei Zhang, Yuan Liu, Guixiu Shi
Response to: ‘Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial’’ by Wang et al
(27 January, 2021) Free
Renaud Felten, Jacques-Eric Gottenberg
Correspondence on ‘Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases’ (18 December, 2020) Free
Sibel Zehra Aydin, Elliot Hepworth, Peter Tugwell
Response to: ‘Correspondence on ‘Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases’’ by Aydin et al
(18 December, 2020) Free
Dalifer Dayanira Freites Nuñez, Leticia Leon, Arkaitz Mucientes, Luis Rodriguez-Rodriguez, Judit Font Urgelles, Alfredo Madrid García, Jose Ignacio Colomer, Juan A Jover, Benjamín Fernandez-Gutierrez, Lydia Abasolo
Correspondence on ‘Preliminary predictive criteria for COVID-19 cytokine storm’ (7 January, 2021) Free
Desiree Tampe, Martin S Winkler, Peter Korsten, Samy Hakroush, Onnen Moerer, Björn Tampe
Response to: ‘Correspondence on ‘Preliminary predictive criteria for COVID-19 cytokine storm’’ by Tampe et al
(7 January, 2021) Free
Roberto Caricchio, Marcello Gallucci, Chandra Dass, Xinyan Zhang, Stefania Gallucci, David Fleece, Michael Bromberg, Gerard J Criner
Systemic lupus erythematosus and COVID-19: what we know so far (28 August, 2020) Free
Giuseppe A. Ramirez, Luca Moroni, Emanuel Della-Torre, Maria Gerosa, Lorenzo Beretta, Enrica P. Bozzolo, Lorenzo Dagna
Repeated false-negative tests delayed diagnosis of COVID-19 in a case with granulomatosis with polyangiitis under maintenance therapy with rituximab and concomitant influenza pneumonia (15 July, 2020) Free
Samy Hakroush, Jonas Franz, Jörg Larsen, Peter Korsten, Martin Sebastian Winkler, Björn Tampe
Comment on: ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al
(21 July, 2020) Free
Samet Karahan, Ali Cetinkaya, Kaniye Aydin, Hatice Aslan Sirakaya
Correction: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
(10 February, 2023) Free

Main menu

Table of contents

March 2023 - Volume 82 - 3

Editorial

Review

Viewpoint

Rheumatoid arthritis

Systemic lupus erythematosus

Systemic sclerosis

Sjögren’s syndrome

Osteoarthritis

Crystal arthropathies

Animal models

Letters

EULAR news

Electronic pages

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

March 2023 - Volume 82 - 3

Editorial

Review

Viewpoint

Rheumatoid arthritis

Systemic lupus erythematosus

Systemic sclerosis

Sjögren’s syndrome

Osteoarthritis

Crystal arthropathies

Animal models

Letters

EULAR news

Electronic pages

Issue Information